Litcius/Paper detail

RNA-dependent assembly of chimeric antigen nanoparticles as an efficient H5N1 pre-pandemic vaccine platform

Jongkwan Lim, Yucheol Cheong, Young Seok Kim, Wonil Chae, Beom Jeung Hwang, Jinhee Lee, Yo Han Jang, Young Hoon Roh, Sang‐Uk Seo, Baik Lin Seong

2021Nanomedicine Nanotechnology Biology and Medicine10 citationsDOIOpen Access PDF

Abstract

Highly pathogenic avian influenza viruses (HPAIVs) pose a significant threat to human health, with high mortality rates, and require effective vaccines. We showed that, harnessed with novel RNA-mediated chaperone function, hemagglutinin (HA) of H5N1 HPAIV could be displayed as an immunologically relevant conformation on self-assembled chimeric nanoparticles (cNP). A tri-partite monomeric antigen was designed including: i) an RNA-interaction domain (RID) as a docking tag for RNA to enable chaperna function (chaperna: chaperone + RNA), ii) globular head domain (gd) of HA as a target antigen, and iii) ferritin as a scaffold for 24 mer-assembly. The immunization of mice with the nanoparticles (~46 nm) induced a 25-30 fold higher neutralizing capacity of the antibody and provided cross-protection from homologous and heterologous lethal challenges. This study suggests that cNP assembly is conducive to eliciting antibodies against the conserved region in HA, providing potent and broad protective efficacy.

Topics & Concepts

VirologyRNAHeterologousAntigenDocking (animal)Influenza A virus subtype H5N1BiologyHemagglutinin (influenza)AntibodyChemistryMicrobiologyVirusBiochemistryGeneGeneticsMedicineNursingInfluenza Virus Research StudiesRNA and protein synthesis mechanismsAnimal Disease Management and Epidemiology
RNA-dependent assembly of chimeric antigen nanoparticles as an efficient H5N1 pre-pandemic vaccine platform | Litcius